NO972068L - Pharmaceutical composition based on stabilized lipophilic matrices for controlled release of active principles - Google Patents

Pharmaceutical composition based on stabilized lipophilic matrices for controlled release of active principles

Info

Publication number
NO972068L
NO972068L NO972068A NO972068A NO972068L NO 972068 L NO972068 L NO 972068L NO 972068 A NO972068 A NO 972068A NO 972068 A NO972068 A NO 972068A NO 972068 L NO972068 L NO 972068L
Authority
NO
Norway
Prior art keywords
pharmaceutical composition
controlled release
composition based
active principles
lipophilic matrices
Prior art date
Application number
NO972068A
Other languages
Norwegian (no)
Other versions
NO972068D0 (en
NO318227B1 (en
Inventor
Gilles Fonknechten
Patrick Genty
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO972068D0 publication Critical patent/NO972068D0/en
Publication of NO972068L publication Critical patent/NO972068L/en
Publication of NO318227B1 publication Critical patent/NO318227B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)

Abstract

Stabilised lipophilic matrix for controlled release of active agents. Also claimed is a pharmaceutical composition containing the matrix, preferably in the form of a capsule.
NO19972068A 1996-05-06 1997-05-05 Stabilized lipophilic matrix for controlled release of active principles, pharmaceutical composition containing the same and methods for their preparation. NO318227B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9605606A FR2748209B1 (en) 1996-05-06 1996-05-06 PHARMACEUTICAL COMPOSITION BASED ON STABILIZED LIPOPHILIC MATRICES FOR THE CONTROLLED RELEASE OF ACTIVE INGREDIENTS

Publications (3)

Publication Number Publication Date
NO972068D0 NO972068D0 (en) 1997-05-05
NO972068L true NO972068L (en) 1997-11-07
NO318227B1 NO318227B1 (en) 2005-02-21

Family

ID=9491845

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19972068A NO318227B1 (en) 1996-05-06 1997-05-05 Stabilized lipophilic matrix for controlled release of active principles, pharmaceutical composition containing the same and methods for their preparation.

Country Status (16)

Country Link
EP (1) EP0806202B1 (en)
JP (1) JP3983339B2 (en)
CN (1) CN1171270A (en)
AT (1) ATE212543T1 (en)
AU (1) AU720146B2 (en)
CA (1) CA2204475C (en)
DE (1) DE69710121T2 (en)
DK (1) DK0806202T3 (en)
ES (1) ES2170922T3 (en)
FR (1) FR2748209B1 (en)
HU (1) HU222045B1 (en)
NO (1) NO318227B1 (en)
NZ (1) NZ314740A (en)
PL (1) PL190562B1 (en)
PT (1) PT806202E (en)
ZA (1) ZA973836B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1011363A3 (en) * 1997-09-11 1999-08-03 Smb Technology Capsules semi-solid matrix autoemulsionnables a prolonged action.
FR2782006B1 (en) * 1998-08-07 2002-04-19 Gattefosse Ets Sa SUSTAINED RELEASE COMPOSITION CAPABLE OF FORMING MICRO-EMULSION
DE10161078A1 (en) * 2001-12-12 2003-08-28 Achim Goepferich Matrices for the stabilization and controlled release of problem drugs
WO2005016312A1 (en) 2003-08-13 2005-02-24 Nobex Corporation Micro-particle fatty acid salt solid dosage formulations for therapeutic agents
GB0324574D0 (en) * 2003-10-21 2003-11-26 Glaxo Group Ltd Novel compositions
CA2627292C (en) 2005-10-26 2012-04-17 Banner Pharmacaps, Inc. Hydrophilic vehicle-based dual controlled release matrix system
US8293270B2 (en) 2005-10-26 2012-10-23 Banner Pharmacaps, Inc. Lipophilic vehicle-based dual controlled release matrix system
US8198268B2 (en) 2008-10-31 2012-06-12 Janssen Biotech, Inc. Tianeptine sulfate salt forms and methods of making and using the same
JP2013119540A (en) * 2011-12-08 2013-06-17 Nipro Corp Solid pharmaceutical composition and method for producing the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797286A (en) * 1985-11-12 1989-01-10 Eli Lilly And Company Orally administerable sustained release pharmaceutical formulations
DE4413350A1 (en) * 1994-04-18 1995-10-19 Basf Ag Retard matrix pellets and process for their production
US5545628A (en) * 1995-01-10 1996-08-13 Galephar P.R. Inc. Pharmaceutical composition containing fenofibrate

Also Published As

Publication number Publication date
EP0806202A1 (en) 1997-11-12
NO972068D0 (en) 1997-05-05
HU9700842D0 (en) 1997-06-30
NZ314740A (en) 1998-11-25
FR2748209B1 (en) 1998-06-05
PL319808A1 (en) 1997-11-10
PT806202E (en) 2002-06-28
CA2204475A1 (en) 1997-11-06
DK0806202T3 (en) 2002-05-06
HUP9700842A1 (en) 1998-08-28
JP3983339B2 (en) 2007-09-26
DE69710121T2 (en) 2002-11-28
EP0806202B1 (en) 2002-01-30
AU720146B2 (en) 2000-05-25
CN1171270A (en) 1998-01-28
AU1999197A (en) 1997-11-13
DE69710121D1 (en) 2002-03-14
FR2748209A1 (en) 1997-11-07
PL190562B1 (en) 2005-12-30
ES2170922T3 (en) 2002-08-16
ATE212543T1 (en) 2002-02-15
JPH1045629A (en) 1998-02-17
ZA973836B (en) 1997-12-02
CA2204475C (en) 2002-12-03
NO318227B1 (en) 2005-02-21
HU222045B1 (en) 2003-04-28

Similar Documents

Publication Publication Date Title
EP0350246A3 (en) Sustained release microcapsule for water soluble drug
FR2653338B1 (en) FORMULATION FOR SUSTAINED RELEASE DRUGS AND THE USE THEREOF.
DE3784594T2 (en) Pharmaceutical compositions containing microcapsules.
FR2683146B1 (en) PHARMACEUTICAL COMPOSITIONS WITH CONTROLLED RELEASE OF THE DRUG SUBSTANCE.
GR3035308T3 (en) Bioadhesive pharmaceutical composition for controlled release of drugs.
IL107398A0 (en) Prodrugs, their preparation and use as pharmaceuticals
DE69307977D1 (en) Stabilized derivatives of pharmaceutical compositions containing vitamin D2 and D3
AU1834392A (en) Matrix tablet permitting the sustained release of indapamide after oral administration
DE59804823D1 (en) DRUG FORMULATION WITH CONTROLLED ACTIVE SUBSTANCE RELEASE
NO972068D0 (en) Pharmaceutical composition based on stabilized lipophilic matrices for controlled release of active principles
HUT75029A (en) Systems for controlled release of pilocarpine, and semipermeable capsule containing the active ingredient
HUT50787A (en) Process for producing pharmaceutical compositions comprising 4-aryl-4-piperidine-, pyrrolidine- or hexahydroazepincarbinol derivatives or heterocyclic analogs thereof as active ingredient and process for producing the new compounds
ATE80797T1 (en) DELAYED-RELEASE MEDICATIONS CONTAINING HEMICELLULOSIS MATRIX.
DE69318153T2 (en) ANTIHYPERCHOLESTERICALLY ACTIVE COMPOUNDS, PHARMACEUTICAL PREPARATIONS AND USES THEREOF
GB2246072B (en) Solid pharmaceutical compositions containing a light sensitive active ingred ient and stabilised by a dye
ATA124091A (en) PHARMACEUTICAL PREPARATION CONTAINING A THROMBOLYTICALLY ACTIVE SUBSTANCE
HUT47205A (en) Stabilized solid insecticides containing as active substance s,s'-(2)dimethyl-amin(-trimethilen-)bis-(benzosulphonate)
DE58905106D1 (en) NEW MEDICINES CONTAINING 1,2-DITHIOL-3-THION-S-OXIDE COMPOUNDS.
NO170282C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,4-DIAZEPINE DERIVATIVES
DE68902056T2 (en) 4-AROYLIMIDAZOL-2-ON CONTAINING PHARMACEUTICAL COMPOSITION.
DE69416034T2 (en) Pharmaceutical preparation for rectal administration of pharmacologically active compounds
EP0305194A3 (en) Veterinary composition
HUT51626A (en) Process for producing 5-substituted amino-8-phenyl or substituted phenyl-3h,6h-1,4,5a,8a-tetraaza-ceanaphthylene-3-ones and pharmaceutical preparations containing these compounds
DE68907091T2 (en) Pharmaceutical tablets and capsule granules containing scleroglucan and active ingredient.
KR970000225A (en) Anti-depressant drug containing cinephrine as an active ingredient

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees